Erik Harris
EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical · 3 reported transactions in 2 companies · latest trade Mar 2, 2026
Their trades
Sold | Mar 2, 2026 | Mar 2, 2026 close $23.02 → Oct 30, 2026 close $16.10. S&P 500 +10.1% over the same days. |
$240.3K
Mar 2, 2026 close $23.02 → Oct 30, 2026 close $16.10. S&P 500 +10.1% over the same days.